5. Conclusion
Our findings demonstrate thata combination of adjuvant treatmentwith HFCWO may help children withM. pneumoniae pneumonia to achieve clear improvements in clinical symptoms, reduce the length of hospital stays, and reduce costs. Further studies, incorporating multiple centers, are now needed to evaluate clinical efficacy, tolerability, adverse effects, and cost effectiveness.